首页> 外文期刊>Urology >Effect of Kallikrein-related Peptidase KLK1 on Ameliorating Spermatogenesis Regeneration in Busulfan-induced Azoospermic Mice and Promoting Mouse Spermatogonial Stem Cell Proliferation In Vitro
【24h】

Effect of Kallikrein-related Peptidase KLK1 on Ameliorating Spermatogenesis Regeneration in Busulfan-induced Azoospermic Mice and Promoting Mouse Spermatogonial Stem Cell Proliferation In Vitro

机译:Kallikrein相关肽酶KLK1对血红素甘草植物小鼠改善精子发生再生的影响,促进小鼠精术干细胞增殖体外

获取原文
获取原文并翻译 | 示例
       

摘要

ObjectivesTo investigate the effect of kallikrein-related peptidase KLK1 on azoospermic mice induced by busulfan and mouse spermatogonial stem cell. MethodsMice were treated with a single intraperitoneal injection of busulfan, and 4 weeks later, they received a daily intraperitoneal injection of KLK1 at different doses for another 4 weeks. Eight weeks after the busulfan treatment, all mice were sacrificed and their testes were collected for histological evaluation, immunostaining and protein extraction. In vitro, immortalized mouse spermatogonial stem cells, namely C18-4 cells, were treated with KLK1 for proliferation assays. ResultsHistological evaluation of testes, epididymis and epididymal fluid showed that KLK1-treated mice had better spermatogenesis than the control group. Immunostaining showed that tissue samples from testes of KLK1-treated mice had more PLZF- and SCP3-positive cells per seminiferous tubule as well as more PNA-positive cells in the seminiferous tubules. Western blots revealed higher expression levels of PCNA in KLK1-treated mice than in control mice. C18-4 cells treated with KLK1 had a higher proliferation rate and higher expression levels of PCNA, Cyclin A and Cyclin E, and the level of phosphorylated ERK2 were increased after KLK1 treatment. ConclusionCollectively, KLK1 can improve spermatogenesis in azoospermic mice, and KLK1 can promote the proliferation of mouse spermatogonial stem cells via activating ERK1/2 and cell cycle proteins Cyclin A and Cyclin E. This study could offer novel approach and provide new targets for the treatment of azoospermia.
机译:Objectivesto探讨Kallikrein相关的肽酶KLK1对Busulfan和小鼠精子干细胞诱导的偶氮孢子小鼠的影响。方法用单一的腹腔注射Busulfan治疗,4周后,它们在另外4周内以不同剂量的每日腹膜内注射KLK1。八周后,八周后,牺牲所有小鼠,收集其睾丸以进行组织学评价,免疫染色和蛋白质提取。在体外,用KLK1处理不变的小鼠精子干细胞,即C18-4细胞以进行增殖测定。结果表观评估睾丸,附睾和附睾流体表明,KLK1处理的小鼠具有比对照组更好的精子发生。免疫染色表明,来自KLK1处理的小鼠的睾丸的组织样品具有每种半成小管的PLZF和SCP3阳性细胞以及嗜聚小管中的更多PNA阳性细胞。 Western印迹显示出比对照小鼠的KLK1处理小鼠在KLK1处理的小鼠中更高的表达水平。用KLK1处理的C18-4细胞具有较高的增殖速率和更高的PCNA,细胞周期蛋白A和细胞周期蛋白E的表达水平,并且在KLK1处理后增加了磷酸化ERK2的水平。结论可培养基,KLK1可以通过激活ERK1 / 2和细胞周期蛋白A和细胞周期E促进KLK1可以通过激活ERK1 / 2和细胞周期蛋白质促进小鼠精蛋白干细胞的增殖。该研究可以提供新的方法并为治疗提供新的方法Azoospermia。

著录项

  • 来源
    《Urology》 |2018年第2018期|共8页
  • 作者单位

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

    School of Medicine Hunan Normal University;

    Department of Andrology the Center for Men's Health Urologic Medical Center Shanghai Key;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 泌尿科学(泌尿生殖系疾病);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号